<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35866289</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>Cognitive reserve protects ALS-typical cognitive domains: A longitudinal study.</ArticleTitle><Pagination><StartPage>1212</StartPage><EndPage>1223</EndPage><MedlinePgn>1212-1223</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51623</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">To determine whether cognitive reserve (CR) as measured by verbal intelligence quotient, educational length, and achievement protects amyotrophic lateral sclerosis (ALS) patients' verbal fluency, executive functioning, and memory against brain volume loss over a period of 12&#x2009;months.</AbstractText><AbstractText Label="METHODS">This cohort study was completed between 2013 and 2016 with a follow-up duration of 12&#x2009;months. ALS patients were recruited from two specialist out-patient clinics in Rostock and Magdeburg in Germany. Participants underwent cognitive testing and magnetic resonance imaging both at baseline and again after 12&#x2009;months. The cognitive domains assessed included verbal memory in addition to executive functions such as verbal fluency, working memory, shifting and selective attention.</AbstractText><AbstractText Label="RESULTS">Thirty-eight ALS patients took part; 25 patients had no cognitive impairment (ALSni), and 13 were cognitively impaired (ALSci). On average, patients lost 294&#x2009;mm<sup>3</sup> in their superior frontal gyri, 225&#x2009;mm<sup>3</sup> in their orbitofrontal gyri, and 15.97&#x2009;mm<sup>3</sup> in their hippocampi over 12&#x2009;months. There was strong evidence that CR protected letter fluency from further decline (Bayes factor [BF] &gt;10) and moderate evidence that it supported learning effects in letter flexibility (BF&#x2009;&gt;3). However, there is a lack of evidence supporting the notion that working memory, shifting, selective attention or verbal memory (BF&#x2009;=&#x2009;1) are protected.</AbstractText><AbstractText Label="DISCUSSION">As CR is easily determined and protects ALS-specific cognitive domains over time, it should be regarded as a valuable predictive marker.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Temp</LastName><ForeName>Anna G M</ForeName><Initials>AGM</Initials><Identifier Source="ORCID">0000-0003-0671-121X</Identifier><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE), Rostock-Greifswald, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Neurodegeneration Section&#xa0;"Albrecht Kossel", Department of Neurology, University Medical Centre, Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Medical Centre, Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurozentrum, Berufsgenossenschaftliches Klinikum Hamburg, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasper</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE), Rostock-Greifswald, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Medical Centre, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machts</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>German Centre for Neurodegenerative Diseases, Site Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vielhaber</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>German Centre for Neurodegenerative Diseases, Site Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teipel</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3586-3194</Identifier><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE), Rostock-Greifswald, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychosomatic Medicine, University Medical Centre, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermann</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7364-7791</Identifier><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE), Rostock-Greifswald, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Neurodegeneration Section&#xa0;"Albrecht Kossel", Department of Neurology, University Medical Centre, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prudlo</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE), Rostock-Greifswald, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Medical Centre, Rostock, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058245" MajorTopicYN="Y">Cognitive Reserve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>S. T. declares the following (all in Germany): MSD Sharp &amp; Dohme GmbH, Lindenplatz 1, 85549 Haar; 11/09/2018: talk &#x201c;Dementia and Diabetes&#x2013;current report&#x201d; at the quality circle for physicians in K&#xfc;hlungsborn; 14/11/2018: MSD expert forum NAB Alzheimer in Munich, participant as consultant; 13/08/2019: talk &#x201c;Dementia and Diabetes&#x2013;current report&#x201d; at the event &#x201c;Dementia and Diabetes&#x201d; in Rostock; ROCHE Pharma AG, Emil&#x2010;Barell&#x2010;Str. 1, 79639 Grenzach&#x2010;Wyhlen; 12/09/2019: 3rd National Advisory Board for ROCHE Pharma AG, Frankfurt (Main), participant as consultant; 27/09/2019: talk &#x201c;Amyloid as target for diagnosis and treatment in Alzheimer's disease&#x201d; at the ROCHE Symposium at the DGN Congress in Stuttgart; 09/2020: Advisory board Biogen, Biogen GmbH, Riedenburger Stra&#xdf;e 7, 81677. Munich; 01/22/2021: online expert discussion &#x201c;Mild Cognitive Impairment&#x201d;, talk &#x201c;MCI Epidemiology&#x201d;, Dr. Willmar Schwabe GmbH &amp; Co. KG, Willmar&#x2010;Schwabe&#x2010;Str. 4, 76227 Karlsruhe; 25/03/2021: virtual advisory board &#x201c;National Alzheimer Advisory Board&#x201d;, consultant, Roche Pharma AG, Emil&#x2010;Barell&#x2010;Str. 1, 79639 Grenzach&#x2010;Wyhlen. A.H. received. royalties from BIOGEN and DESITIN for advisory board meetings. A. H. has received honoraria from Biogen and Desitin as a consultant.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>22</Day><Hour>3</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35866289</ArticleId><ArticleId IdType="pmc">PMC9380174</ArticleId><ArticleId IdType="doi">10.1002/acn3.51623</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Beswick E, Park E, Wong C, et&#xa0;al. A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis. J Neurol. 2020;268:4510&#x2010;4521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8563523</ArticleId><ArticleId IdType="pubmed">32910255</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, Delgadillo D, Piquard A, et&#xa0;al. The range and clinical impact of cognitive impairment in French patients with ALS: a cross&#x2010;sectional study of neuropsychological test performance. Amyotroph Lateral Scler. 2011;12:372&#x2010;378.</Citation><ArticleIdList><ArticleId IdType="pubmed">21585273</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Bede P, Montuschi A, Pender N, Chio A, Hardiman O. Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm. J Neurol. 2015;262:1447&#x2010;1454.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4469087</ArticleId><ArticleId IdType="pubmed">25860344</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Vignola A, Mastro E, et&#xa0;al. Neurobehavioral symptoms in ALS are negatively related to caregivers' burden and quality of life. Eur J Neurol. 2010;17:1298&#x2010;1303.</Citation><ArticleIdList><ArticleId IdType="pubmed">20402747</ArticleId></ArticleIdList></Reference><Reference><Citation>Temp AGM, Prudlo J, Vielhaber S, et&#xa0;al. Cognitive reserve and regional brain volume in amyotrophic lateral sclerosis. Cortex. 2021;139:240&#x2010;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">33892294</ArticleId></ArticleIdList></Reference><Reference><Citation>Costello E, Rooney J, Pinto&#x2010;Grau M, et&#xa0;al. Cognitive reserve in amyotrophic lateral sclerosis (ALS): a population&#x2010;based longitudinal study. J Neurol Neurosurg Psychiatry. 2021;92:460&#x2010;465.</Citation><ArticleIdList><ArticleId IdType="pubmed">33563807</ArticleId></ArticleIdList></Reference><Reference><Citation>Consonni M, Dalla Bella E, Bersano E, Telesca A, Lauria G. Cognitive reserve is associated with altered clinical expression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:237&#x2010;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">33263428</ArticleId></ArticleIdList></Reference><Reference><Citation>Canosa A, Palumbo F, Iazzolino B, et&#xa0;al. The interplay among education, brain metabolism, and cognitive impairment suggests a role of cognitive reserve in amyotrophic lateral sclerosis. Neurobiol Aging. 2021;98:205&#x2010;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">33316576</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern Y, Arenaza&#x2010;Urquijo EM, Bartres&#x2010;Faz D, et&#xa0;al. Whitepaper: defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimers Dement. 2020;16:1305&#x2010;1311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417987</ArticleId><ArticleId IdType="pubmed">30222945</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern Y. Cognitive reserve. Neuropsychologia. 2009;47:2015&#x2010;2028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2739591</ArticleId><ArticleId IdType="pubmed">19467352</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper E, Zydatiss K, Schuster C, et&#xa0;al. No change in executive performance in ALS patients: a longitudinal neuropsychological study. Neurodegener Dis. 2016;16:184&#x2010;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">26613522</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Bede P, Byrne S, et&#xa0;al. Cognitive changes predict functional decline in ALS: a population&#x2010;based longitudinal study. Neurology. 2013;80:1590&#x2010;1597.</Citation><ArticleIdList><ArticleId IdType="pubmed">23553481</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber H, Gaigalat T, Wiedemuth&#x2010;Catrinescu U, et&#xa0;al. Cognitive function in bulbar&#x2010; and spinal&#x2010;onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients. J Neurol. 2005;252:772&#x2010;781.</Citation><ArticleIdList><ArticleId IdType="pubmed">15742104</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Ferraro PM, Riva N, et&#xa0;al. Structural brain correlates of cognitive and behavioral impairment in MND. Hum Brain Mapp. 2016;37:1614&#x2010;1626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6867462</ArticleId><ArticleId IdType="pubmed">26833930</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Iyer PM, Schuster C, et&#xa0;al. The selective anatomical vulnerability of ALS: &#x2018;disease&#x2010;defining&#x2019; and &#x2018;disease&#x2010;defying&#x2019; brain regions. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:561&#x2010;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">27087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Omer T, Finegan E, Hutchinson S, et&#xa0;al. Neuroimaging patterns along the ALS&#x2010;FTD spectrum: a multiparametric imaging study. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:611&#x2010;623.</Citation><ArticleIdList><ArticleId IdType="pubmed">28562080</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Hardiman O. Longitudinal structural changes in ALS: a three time&#x2010;point imaging study of white and gray matter degeneration. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:232&#x2010;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">29214883</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Burgh HK, Westeneng HJ, Walhout R, et&#xa0;al. Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis. Neurology. 2020;94:e2592&#x2010;e2604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7455328</ArticleId><ArticleId IdType="pubmed">32414878</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron D . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293&#x2010;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, et&#xa0;al. Amyotrophic lateral sclerosis &#x2010; frontotemporal spectrum disorder (ALS&#x2010;FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:153&#x2010;174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, et&#xa0;al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456&#x2010;2477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Machts J, Keute M, Kaufmann J, et&#xa0;al. Longitudinal clinical and neuroanatomical correlates of memory impairment in motor neuron disease. Neuroimage Clin. 2021;29:102545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7786131</ArticleId><ArticleId IdType="pubmed">33387861</ArticleId></ArticleIdList></Reference><Reference><Citation>Benbrika S, Doidy F, Carluer L, et&#xa0;al. Longitudinal study of cognitive and emotional alterations in amyotrophic lateral sclerosis: clinical and imaging data. Front Neurol. 2021;12:620198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8296637</ArticleId><ArticleId IdType="pubmed">34305771</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, et&#xa0;al. A revision of the El Escorial criteria-2015. Amyotroph lateral scler frontotemporal degener. 2015;16:291&#x2010;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Temp AGM, Dyrba M, Kasper E, Teipel S, Prudlo J. Case report: cognitive conversion in a non&#x2010;Brazilian VAPB mutation carrier (ALS8). Front Neurol. 2021;12:668772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8208309</ArticleId><ArticleId IdType="pubmed">34149599</ArticleId></ArticleIdList></Reference><Reference><Citation>Funke AD, Esser M, Kruttgen A, et&#xa0;al. The p.P56S mutation in the VAPB gene is not due to a single founder: the first European case. Clin Genet. 2010;77:302&#x2010;303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2847198</ArticleId><ArticleId IdType="pubmed">20447143</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xfc;ger S, Battke F, Sprecher A, et&#xa0;al. Rare variants in neurodegeneration associated genes revealed by targeted panel sequencing in a German ALS cohort. Front Mol Neurosci. 2016;9:92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5061735</ArticleId><ArticleId IdType="pubmed">27790088</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt K&#x2010;H, Metzler P. Wortschatztest. Hogrefe testzentrale; 1992.</Citation></Reference><Reference><Citation>Osmanovic A, Wieselmann G, Mix L, et&#xa0;al. Cognitive performance of patients with adult 5q&#x2010;spinal muscular atrophy and with amyotrophic lateral sclerosis. Brain Sci. 2020;11:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7822456</ArticleId><ArticleId IdType="pubmed">33374658</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschenbrenner S, Tucha O. Regensburger Wortfl&#xfc;ssigkeits Test. Hogrefe Testzentrale; 2001.</Citation></Reference><Reference><Citation>Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271&#x2010;276.</Citation></Reference><Reference><Citation>Helmstaedter C, Lendt M, Lux S. Verbaler Vern&#x2010; und Merkf&#xe4;higkeitstest Weinheim: Beltz Test. 2001.</Citation></Reference><Reference><Citation>Abrahams S, Leigh PN, Harvey A, Vythelingum GN, Gris&#xe9; D, Goldstein LH. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia. 2000;38:734&#x2010;747.</Citation><ArticleIdList><ArticleId IdType="pubmed">10689049</ArticleId></ArticleIdList></Reference><Reference><Citation>Khng KH, Lee K. The relationship between Stroop and stop&#x2010;signal measures of inhibition in adolescents: influences from variations in context and measure estimation. PLoS One. 2014;9:e101356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4081588</ArticleId><ArticleId IdType="pubmed">24992683</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage. 2007;38:95&#x2010;113.</Citation><ArticleIdList><ArticleId IdType="pubmed">17761438</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiology; ACo . Phantom Test guidance for use of the large MRI phantom for the ACR MRI accreditation program. 2018.</Citation></Reference><Reference><Citation>Pettit LD, Bastin ME, Smith C, Bak TH, Gillingwater TH, Abrahams S. Executive deficits, not processing speed relates to abnormalities in distinct prefrontal tracts in amyotrophic lateral sclerosis. Brain. 2013;136:3290&#x2010;3304.</Citation><ArticleIdList><ArticleId IdType="pubmed">24056536</ArticleId></ArticleIdList></Reference><Reference><Citation>Chenji S, Ishaque A, Mah D, et&#xa0;al. Neuroanatomical associations of the Edinburgh cognitive and behavioural ALS screen (ECAS). Brain Imaging Behav. 2021;15:1641&#x2010;1654.</Citation><ArticleIdList><ArticleId IdType="pubmed">33155172</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein LH, Newsom&#x2010;Davis IC, Bryant V, Brammer M, Leigh PN, Simmons A. Altered patterns of cortical activation in ALS patients during attention and cognitive response inhibition tasks. J Neurol. 2011;258:2186&#x2010;2198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3225607</ArticleId><ArticleId IdType="pubmed">21556876</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier SL, Charleston AJ, Tippett LJ. Cognitive and behavioural deficits associated with the orbitomedial prefrontal cortex in amyotrophic lateral sclerosis. Brain. 2010;133:3444&#x2010;3457.</Citation><ArticleIdList><ArticleId IdType="pubmed">20889583</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagenmakers E&#x2010;J, Love J, Marsman M, et&#xa0;al. Bayesian inference for psychology. Part II: example applications with JASP. Psychon Bull Rev. 2018;25:58&#x2010;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5862926</ArticleId><ArticleId IdType="pubmed">28685272</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagenmakers E&#x2010;J, Marsman M, Jamil T, et&#xa0;al. Bayesian inference for psychology. Part I: theoretical advantages and practical ramifications. Psychon Bull Rev. 2018;25:35&#x2010;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5862936</ArticleId><ArticleId IdType="pubmed">28779455</ArticleId></ArticleIdList></Reference><Reference><Citation>JASP (version 0.11.1) [computer program]. 2019.</Citation></Reference><Reference><Citation>Van Doorn J, Van den Bergh D, B&#xf6;hm U, et&#xa0;al. The JASP guidelines for conducting and reporting a Bayesian analysis. Psychon Bull Rev. 2019;28:813&#x2010;826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8219590</ArticleId><ArticleId IdType="pubmed">33037582</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Goldstein LH, Simmons A, et&#xa0;al. Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study. Brain. 2004;127:1507&#x2010;1517.</Citation><ArticleIdList><ArticleId IdType="pubmed">15163610</ArticleId></ArticleIdList></Reference><Reference><Citation>Alladi S, Bak TH, Duggirala V, et&#xa0;al. Bilingualism delays age at onset of dementia, independent of education and immigration status. Neurology. 2013;81:1938&#x2010;1944.</Citation><ArticleIdList><ArticleId IdType="pubmed">24198291</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson RS, Boyle PA, Yu L, Barnes LL, Schneider JA, Bennett DA. Life&#x2010;span cognitive activity, neuropathologic burden, and cognitive aging. Neurology. 2013;81:314&#x2010;321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3772831</ArticleId><ArticleId IdType="pubmed">23825173</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C, Kasper E, Dyrba M, et&#xa0;al. Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis. Neurobiol Aging. 2014;35:240&#x2010;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">23992619</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen D, Hou B, Xu Y, et&#xa0;al. Brain structural and perfusion signature of amyotrophic lateral sclerosis with varying levels of cognitive deficit. Front Neurol. 2018;9:364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5976730</ArticleId><ArticleId IdType="pubmed">29881369</ArticleId></ArticleIdList></Reference><Reference><Citation>Temp AGM, Dyrba M, B&#xfc;ttner C, et&#xa0;al. Cognitive profiles of amyotrophic lateral sclerosis differ in resting&#x2010;state functional connectivity: an fMRI study. Front Neurosci. 2021;15:682100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8261303</ArticleId><ArticleId IdType="pubmed">34248485</ArticleId></ArticleIdList></Reference><Reference><Citation>Canosa A, Pagani M, Cistaro A, et&#xa0;al. 18F&#x2010;FDG&#x2010;PET correlates of cognitive impairment in ALS. Neurology. 2016;86:44&#x2010;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">26590270</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside DM, Kealey T, Semla M, et&#xa0;al. Verbal fluency: language or executive function measure? Appl Neuropsychol Adult. 2016;23:29&#x2010;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">26111011</ArticleId></ArticleIdList></Reference><Reference><Citation>Poldrack RA, Yarkoni T. From brain maps to cognitive ontologies: informatics and the search for mental structure. Annu Rev Psychol. 2016;67:587&#x2010;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4701616</ArticleId><ArticleId IdType="pubmed">26393866</ArticleId></ArticleIdList></Reference><Reference><Citation>Eich T, Parker D, Gazes Y, Razlighi Q, Habeck C, Stern Y. Towards an ontology of cognitive processes and their neural substrates: a structural equation&#xa0;modeling approach. PLoS One. 2020;15:e0228167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7010254</ArticleId><ArticleId IdType="pubmed">32040518</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodich A, Carli G, Cerami C, Iannaccone S, Magnani G, Perani D. Social and cognitive control skills in long&#x2010;life occupation activities modulate the brain reserve in the behavioural variant of frontotemporal dementia. Cortex. 2018;99:311&#x2010;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">29328983</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>